LightNews
charlesrudin.bsky.social
@charlesrudin.bsky.social
27 followers 9 following 2 posts
Posts Media Videos Starter Packs
charlesrudin.bsky.social
charlesrudin.bsky.social @charlesrudin.bsky.social · Jun 2
A big advance for patients with SCLC today —

www.nejm.org/doi/full/10....
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy | NEJM
Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer. Wheth...
www.nejm.org
1 3
charlesrudin.bsky.social
charlesrudin.bsky.social @charlesrudin.bsky.social · May 26
First Bluesky post…
New paper out, following on FOXA observations of the @juliensage.bsky.social lab; nice collaboration with the @joanmassague.bsky.social lab led by a shared post-doc, Kenta Kawasaki www.nature.com/articles/s41...
FOXA2 promotes metastatic competence in small cell lung cancer - Nature Communications
Small cell lung cancer presents high and multi-site metastatic potential. Here, the authors discover that FOXA2, regulated by ASCL1, promotes multi-site metastasis in small cell lung cancer by inducin...
www.nature.com
2 4
© 2025 Lightnews
Home Scholars & Rankings Sitemaps Privacy